Loading…
Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies
Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal a...
Saved in:
Published in: | Diabetologia 2009-09, Vol.52 (9), p.1935-1943 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753 |
---|---|
cites | cdi_FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753 |
container_end_page | 1943 |
container_issue | 9 |
container_start_page | 1935 |
container_title | Diabetologia |
container_volume | 52 |
creator | Horváth, E. M Magenheim, R Kugler, E Vácz, G Szigethy, A Lévárdi, F Kollai, M Szabo, C Lacza, Z |
description | Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal and gestational diabetic (GDM) pregnancy in both maternal and fetal tissues. Methods Blood samples were collected during pregnancy (weeks 16-29 and 36-40), and placental and umbilical cord tissues were harvested after delivery from healthy volunteers and GDM patients subjected to a carbohydrate-restricted diet or insulin treatment. Immunohistochemical staining was performed on leucocytes and tissue sections using anti-nitrotyrosine (NT), anti-poly(ADP-ribose) (PAR) and anti-apoptosis inducing factor antibodies. Results In healthy pregnancies the intensity of NT and PAR staining of leucocytes correlated positively with gestational week (R ² = 0.43, p < 0.01 and R ² = 0.49, p < 0.001, respectively). In patients on a carbohydrate-restricted diet PAR staining was already strong in weeks 16-29 (p < 0.001 vs control) and did not increase further. In weeks 16-29 there was a correlation between PAR staining and the 2 h value of the oral glucose tolerance test (R ² = 0.49, p < 0.001). Patients with the highest level of leucocyte PARP activity later required insulin therapy, which decreased the intensity of NT and PAR staining. Placental and umbilical cord tissues also had a higher level of nitrative stress markers in GDM pregnancies, but the highest level of PARP activity was observed after insulin therapy. Conclusions/interpretation Continuous elevation of tyrosine nitration and PARP activation may be considered physiological during pregnancy. However, the high level of PARP activity in early pregnancy may signal the subsequent development of severe GDM. |
doi_str_mv | 10.1007/s00125-009-1435-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_213845718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1823803541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753</originalsourceid><addsrcrecordid>eNp9kE-LFDEQxYMo7rj6AbxoIwh6iFYlnXRyXNa_sKigC95CdZKe7bWne0x6hPn2ZqYH9-YpIe_3ql4eY08R3iBA8zYDoFAcwHKspeLyHluVi-BQC3OfrQ4yR6N_nrFHOd8CgFS1fsjO0CrbGIAV-_WlnxPN_Z9Y5TnFnCsaQ7Wdhv2ri3ffeOrbKcfXx4dNTJRjRb7QxTGNVT9WN5GG-WZ_dK1jno8CDVXoqY1z76ttiuuRRt_H_Jg96GjI8cnpPGfXH97_uPzEr75-_Hx5ccV9rZuZW6mDtEim9S2EKMh3tSfdkVLC1iQF6EAUrAooMApEGazpGiO8MDo0Sp6zF8vcbZp-70oodzvtUkmVnUBpatWgKRAukE9Tzil2bpv6DaW9Q3CHdt3SrivtukO7ThbPs9PgXbuJ4c5xqrMAL08AZU9Dlw4fz_84gUZZqOvCiYXLRRrXMd0l_N_254upo8nROpXB198FoATUWhsj5F-xtpwH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213845718</pqid></control><display><type>article</type><title>Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies</title><source>Springer Link</source><creator>Horváth, E. M ; Magenheim, R ; Kugler, E ; Vácz, G ; Szigethy, A ; Lévárdi, F ; Kollai, M ; Szabo, C ; Lacza, Z</creator><creatorcontrib>Horváth, E. M ; Magenheim, R ; Kugler, E ; Vácz, G ; Szigethy, A ; Lévárdi, F ; Kollai, M ; Szabo, C ; Lacza, Z</creatorcontrib><description>Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal and gestational diabetic (GDM) pregnancy in both maternal and fetal tissues. Methods Blood samples were collected during pregnancy (weeks 16-29 and 36-40), and placental and umbilical cord tissues were harvested after delivery from healthy volunteers and GDM patients subjected to a carbohydrate-restricted diet or insulin treatment. Immunohistochemical staining was performed on leucocytes and tissue sections using anti-nitrotyrosine (NT), anti-poly(ADP-ribose) (PAR) and anti-apoptosis inducing factor antibodies. Results In healthy pregnancies the intensity of NT and PAR staining of leucocytes correlated positively with gestational week (R ² = 0.43, p < 0.01 and R ² = 0.49, p < 0.001, respectively). In patients on a carbohydrate-restricted diet PAR staining was already strong in weeks 16-29 (p < 0.001 vs control) and did not increase further. In weeks 16-29 there was a correlation between PAR staining and the 2 h value of the oral glucose tolerance test (R ² = 0.49, p < 0.001). Patients with the highest level of leucocyte PARP activity later required insulin therapy, which decreased the intensity of NT and PAR staining. Placental and umbilical cord tissues also had a higher level of nitrative stress markers in GDM pregnancies, but the highest level of PARP activity was observed after insulin therapy. Conclusions/interpretation Continuous elevation of tyrosine nitration and PARP activation may be considered physiological during pregnancy. However, the high level of PARP activity in early pregnancy may signal the subsequent development of severe GDM.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-009-1435-3</identifier><identifier>PMID: 19597800</identifier><language>eng</language><publisher>Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag</publisher><subject>Adult ; Apoptosis ; Biological and medical sciences ; Birth Weight ; Blood Glucose - analysis ; Body Mass Index ; Carbohydrates ; Diabetes, Gestational - blood ; Diabetes, Gestational - drug therapy ; Diabetes, Gestational - enzymology ; Diabetes. Impaired glucose tolerance ; Diet, Diabetic ; Dietary restrictions ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Enzyme Activation ; Female ; Gestational diabetes ; Glucose ; Glucose Tolerance Test ; Human Physiology ; Humans ; Hypoglycemic Agents - therapeutic use ; Infant, Newborn ; Infant, Small for Gestational Age ; Insulin ; Insulin - therapeutic use ; Internal Medicine ; Leukocytes ; Leukocytes - cytology ; Medical sciences ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Obstetric Labor, Premature ; Oxidative stress ; Parity ; Physiology ; Poly(ADP-ribose) Polymerases - metabolism ; Pregnancy ; Pregnancy - blood ; Pregnancy - physiology ; Reference Values ; Umbilical cord ; Weight Gain</subject><ispartof>Diabetologia, 2009-09, Vol.52 (9), p.1935-1943</ispartof><rights>Springer-Verlag 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753</citedby><cites>FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21859044$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19597800$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horváth, E. M</creatorcontrib><creatorcontrib>Magenheim, R</creatorcontrib><creatorcontrib>Kugler, E</creatorcontrib><creatorcontrib>Vácz, G</creatorcontrib><creatorcontrib>Szigethy, A</creatorcontrib><creatorcontrib>Lévárdi, F</creatorcontrib><creatorcontrib>Kollai, M</creatorcontrib><creatorcontrib>Szabo, C</creatorcontrib><creatorcontrib>Lacza, Z</creatorcontrib><title>Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal and gestational diabetic (GDM) pregnancy in both maternal and fetal tissues. Methods Blood samples were collected during pregnancy (weeks 16-29 and 36-40), and placental and umbilical cord tissues were harvested after delivery from healthy volunteers and GDM patients subjected to a carbohydrate-restricted diet or insulin treatment. Immunohistochemical staining was performed on leucocytes and tissue sections using anti-nitrotyrosine (NT), anti-poly(ADP-ribose) (PAR) and anti-apoptosis inducing factor antibodies. Results In healthy pregnancies the intensity of NT and PAR staining of leucocytes correlated positively with gestational week (R ² = 0.43, p < 0.01 and R ² = 0.49, p < 0.001, respectively). In patients on a carbohydrate-restricted diet PAR staining was already strong in weeks 16-29 (p < 0.001 vs control) and did not increase further. In weeks 16-29 there was a correlation between PAR staining and the 2 h value of the oral glucose tolerance test (R ² = 0.49, p < 0.001). Patients with the highest level of leucocyte PARP activity later required insulin therapy, which decreased the intensity of NT and PAR staining. Placental and umbilical cord tissues also had a higher level of nitrative stress markers in GDM pregnancies, but the highest level of PARP activity was observed after insulin therapy. Conclusions/interpretation Continuous elevation of tyrosine nitration and PARP activation may be considered physiological during pregnancy. However, the high level of PARP activity in early pregnancy may signal the subsequent development of severe GDM.</description><subject>Adult</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Birth Weight</subject><subject>Blood Glucose - analysis</subject><subject>Body Mass Index</subject><subject>Carbohydrates</subject><subject>Diabetes, Gestational - blood</subject><subject>Diabetes, Gestational - drug therapy</subject><subject>Diabetes, Gestational - enzymology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diet, Diabetic</subject><subject>Dietary restrictions</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Enzyme Activation</subject><subject>Female</subject><subject>Gestational diabetes</subject><subject>Glucose</subject><subject>Glucose Tolerance Test</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Infant, Newborn</subject><subject>Infant, Small for Gestational Age</subject><subject>Insulin</subject><subject>Insulin - therapeutic use</subject><subject>Internal Medicine</subject><subject>Leukocytes</subject><subject>Leukocytes - cytology</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases</subject><subject>Obstetric Labor, Premature</subject><subject>Oxidative stress</subject><subject>Parity</subject><subject>Physiology</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Pregnancy</subject><subject>Pregnancy - blood</subject><subject>Pregnancy - physiology</subject><subject>Reference Values</subject><subject>Umbilical cord</subject><subject>Weight Gain</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kE-LFDEQxYMo7rj6AbxoIwh6iFYlnXRyXNa_sKigC95CdZKe7bWne0x6hPn2ZqYH9-YpIe_3ql4eY08R3iBA8zYDoFAcwHKspeLyHluVi-BQC3OfrQ4yR6N_nrFHOd8CgFS1fsjO0CrbGIAV-_WlnxPN_Z9Y5TnFnCsaQ7Wdhv2ri3ffeOrbKcfXx4dNTJRjRb7QxTGNVT9WN5GG-WZ_dK1jno8CDVXoqY1z76ttiuuRRt_H_Jg96GjI8cnpPGfXH97_uPzEr75-_Hx5ccV9rZuZW6mDtEim9S2EKMh3tSfdkVLC1iQF6EAUrAooMApEGazpGiO8MDo0Sp6zF8vcbZp-70oodzvtUkmVnUBpatWgKRAukE9Tzil2bpv6DaW9Q3CHdt3SrivtukO7ThbPs9PgXbuJ4c5xqrMAL08AZU9Dlw4fz_84gUZZqOvCiYXLRRrXMd0l_N_254upo8nROpXB198FoATUWhsj5F-xtpwH</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Horváth, E. M</creator><creator>Magenheim, R</creator><creator>Kugler, E</creator><creator>Vácz, G</creator><creator>Szigethy, A</creator><creator>Lévárdi, F</creator><creator>Kollai, M</creator><creator>Szabo, C</creator><creator>Lacza, Z</creator><general>Berlin/Heidelberg : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20090901</creationdate><title>Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies</title><author>Horváth, E. M ; Magenheim, R ; Kugler, E ; Vácz, G ; Szigethy, A ; Lévárdi, F ; Kollai, M ; Szabo, C ; Lacza, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Birth Weight</topic><topic>Blood Glucose - analysis</topic><topic>Body Mass Index</topic><topic>Carbohydrates</topic><topic>Diabetes, Gestational - blood</topic><topic>Diabetes, Gestational - drug therapy</topic><topic>Diabetes, Gestational - enzymology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diet, Diabetic</topic><topic>Dietary restrictions</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Enzyme Activation</topic><topic>Female</topic><topic>Gestational diabetes</topic><topic>Glucose</topic><topic>Glucose Tolerance Test</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Infant, Newborn</topic><topic>Infant, Small for Gestational Age</topic><topic>Insulin</topic><topic>Insulin - therapeutic use</topic><topic>Internal Medicine</topic><topic>Leukocytes</topic><topic>Leukocytes - cytology</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases</topic><topic>Obstetric Labor, Premature</topic><topic>Oxidative stress</topic><topic>Parity</topic><topic>Physiology</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Pregnancy</topic><topic>Pregnancy - blood</topic><topic>Pregnancy - physiology</topic><topic>Reference Values</topic><topic>Umbilical cord</topic><topic>Weight Gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horváth, E. M</creatorcontrib><creatorcontrib>Magenheim, R</creatorcontrib><creatorcontrib>Kugler, E</creatorcontrib><creatorcontrib>Vácz, G</creatorcontrib><creatorcontrib>Szigethy, A</creatorcontrib><creatorcontrib>Lévárdi, F</creatorcontrib><creatorcontrib>Kollai, M</creatorcontrib><creatorcontrib>Szabo, C</creatorcontrib><creatorcontrib>Lacza, Z</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horváth, E. M</au><au>Magenheim, R</au><au>Kugler, E</au><au>Vácz, G</au><au>Szigethy, A</au><au>Lévárdi, F</au><au>Kollai, M</au><au>Szabo, C</au><au>Lacza, Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>52</volume><issue>9</issue><spage>1935</spage><epage>1943</epage><pages>1935-1943</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal and gestational diabetic (GDM) pregnancy in both maternal and fetal tissues. Methods Blood samples were collected during pregnancy (weeks 16-29 and 36-40), and placental and umbilical cord tissues were harvested after delivery from healthy volunteers and GDM patients subjected to a carbohydrate-restricted diet or insulin treatment. Immunohistochemical staining was performed on leucocytes and tissue sections using anti-nitrotyrosine (NT), anti-poly(ADP-ribose) (PAR) and anti-apoptosis inducing factor antibodies. Results In healthy pregnancies the intensity of NT and PAR staining of leucocytes correlated positively with gestational week (R ² = 0.43, p < 0.01 and R ² = 0.49, p < 0.001, respectively). In patients on a carbohydrate-restricted diet PAR staining was already strong in weeks 16-29 (p < 0.001 vs control) and did not increase further. In weeks 16-29 there was a correlation between PAR staining and the 2 h value of the oral glucose tolerance test (R ² = 0.49, p < 0.001). Patients with the highest level of leucocyte PARP activity later required insulin therapy, which decreased the intensity of NT and PAR staining. Placental and umbilical cord tissues also had a higher level of nitrative stress markers in GDM pregnancies, but the highest level of PARP activity was observed after insulin therapy. Conclusions/interpretation Continuous elevation of tyrosine nitration and PARP activation may be considered physiological during pregnancy. However, the high level of PARP activity in early pregnancy may signal the subsequent development of severe GDM.</abstract><cop>Berlin/Heidelberg</cop><pub>Berlin/Heidelberg : Springer-Verlag</pub><pmid>19597800</pmid><doi>10.1007/s00125-009-1435-3</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-186X |
ispartof | Diabetologia, 2009-09, Vol.52 (9), p.1935-1943 |
issn | 0012-186X 1432-0428 |
language | eng |
recordid | cdi_proquest_journals_213845718 |
source | Springer Link |
subjects | Adult Apoptosis Biological and medical sciences Birth Weight Blood Glucose - analysis Body Mass Index Carbohydrates Diabetes, Gestational - blood Diabetes, Gestational - drug therapy Diabetes, Gestational - enzymology Diabetes. Impaired glucose tolerance Diet, Diabetic Dietary restrictions Endocrine pancreas. Apud cells (diseases) Endocrinopathies Enzyme Activation Female Gestational diabetes Glucose Glucose Tolerance Test Human Physiology Humans Hypoglycemic Agents - therapeutic use Infant, Newborn Infant, Small for Gestational Age Insulin Insulin - therapeutic use Internal Medicine Leukocytes Leukocytes - cytology Medical sciences Medicine Medicine & Public Health Metabolic Diseases Obstetric Labor, Premature Oxidative stress Parity Physiology Poly(ADP-ribose) Polymerases - metabolism Pregnancy Pregnancy - blood Pregnancy - physiology Reference Values Umbilical cord Weight Gain |
title | Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A17%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitrative%20stress%20and%20poly(ADP-ribose)%20polymerase%20activation%20in%20healthy%20and%20gestational%20diabetic%20pregnancies&rft.jtitle=Diabetologia&rft.au=Horv%C3%A1th,%20E.%20M&rft.date=2009-09-01&rft.volume=52&rft.issue=9&rft.spage=1935&rft.epage=1943&rft.pages=1935-1943&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-009-1435-3&rft_dat=%3Cproquest_cross%3E1823803541%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=213845718&rft_id=info:pmid/19597800&rfr_iscdi=true |